Physician profile
Henry A Pretus
NPI 1982661997
$7,462.57
in general payments reported to CMS, 2019-2025
38 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,318 · 2020: $558 · 2021: $639 · 2022: $1,405 · 2023: $797 · 2024: $1,459 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,542.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,566.60 | 2019-2024 | Ranger, Peripheral Rotalink Plus |
| Janssen Pharmaceuticals, INC | $1,186.00 | 2019-2024 | Xarelto |
| Smith+Nephew, INC. | $755.27 | 2019-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Organogenesis INC. | $396.82 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $351.53 | 2019-2023 | Fluency Endovascular Stent Graft |
| Angiodynamics, INC. | $345.30 | 2019-2024 | Auryon Laser System 100-120 Vac |
| Endologix LLC | $322.39 | 2019-2024 | Endocross Device, Torus Stent Graft System |
| Hydrofera LLC | $289.65 | 2023-2024 | Hydrofera Blue |
| Shockwave Medical, INC | $253.77 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $242.60 | 2021-2025 | Hawkone |
| Truvic Medical, INC. | $236.47 | 2022 | |
| Kerecis Limited | $205.28 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Abbott Laboratories | $185.27 | 2022-2024 | Diamondback Peripheral, Jeti All In One Non-Sterile Kit |
| Mimedx Group, INC. | $149.90 | 2024 | |
| Stryker Corporation | $98.37 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $84.81 | 2022-2023 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $79.01 | 2021-2023 | Eliquis |
| Cook Medical LLC | $76.90 | 2020-2025 | Zilver Ptx |
| Medtronic Vascular, INC. | $63.42 | 2019-2020 | |
| Biosense Webster, INC. | $59.52 | 2023-2025 | Carto 3 |
| Philips North America LLC | $56.76 | 2020-2024 | (Az7) Lasers |
| Convatec INC. | $56.62 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.12 | 2023 | Jardiance |
| Cvrx, INC. | $37.78 | 2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.50 | 2023-2024 | Lifevest |
| Terumo Medical Corporation | $31.31 | 2020-2024 | Glidewire |
| Pfizer INC. | $30.64 | 2019-2022 | |
| Penumbra, INC. | $29.01 | 2024 | Penumbra System |
| Becton, Dickinson and Company | $27.93 | 2025 | Rotarexs 6 F X 135 Cm |
| Biom'Up France Sas | $27.07 | 2020 | |
| Acera Surgical, INC. | $25.24 | 2025 | Restrata Wound Matrix |
| Inari Medical, INC. | $20.76 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $18.52 | 2024 | Farxiga |
| Kci USA, INC. | $17.88 | 2021 | |
| Tactile Systems Technology INC | $15.75 | 2023 | Flexitouch Plus, Entre Plus |
| Amgen INC. | $15.74 | 2021 | |
| W. L. Gore & Associates, INC. | $14.82 | 2019 | |
| Alfasigma USA, INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Pretus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.